Brimonidine/timolol

Combination ophthalmic medication for glaucoma and ocular hypertension

Brimonidine/Timolol is a combination ophthalmic medication used for the treatment of glaucoma and ocular hypertension. It consists of two active ingredients:

• Brimonidine: An alpha-2 adrenergic receptor agonist that reduces aqueous humor production and increases uveoscleral outflow.
• Timolol: A non-selective beta-blocker that decreases intraocular pressure (IOP) by reducing aqueous humor production.

This combination is prescribed for patients who require additional intraocular pressure (IOP) reduction beyond monotherapy.

Mechanism of Action

The combination of brimonidine and timolol works synergistically to lower intraocular pressure:

Brimonidine (Alpha-2 Agonist)

• Reduces the production of aqueous humor in the ciliary body.
• Increases uveoscleral outflow, facilitating the drainage of aqueous humor.
• Reduces IOP without significant cardiovascular effects.

Timolol (Beta-Blocker)

• Blocks beta-adrenergic receptors in the ciliary epithelium.
• Decreases aqueous humor production, lowering intraocular pressure.
• Has no significant effect on aqueous humor outflow.

The dual mechanism provides a greater IOP-lowering effect compared to either drug alone.

Indications

Brimonidine/Timolol is primarily indicated for:

• Glaucoma: Specifically primary open-angle glaucoma, where elevated intraocular pressure can damage the optic nerve.
• Ocular hypertension: Increased intraocular pressure without optic nerve damage or visual field loss.

Dosage and Administration

• The typical dosage is one drop in the affected eye(s) twice daily.
• It is administered topically as an ophthalmic solution.
• Patients should wait at least 5 minutes before using other eye medications.
• Contact lenses should be removed before application and reinserted 15 minutes after administration.

Contraindications

Brimonidine/Timolol should not be used in patients with:

• Hypersensitivity to brimonidine, timolol, or excipients in the formulation.
• Bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
• Sinus bradycardia or second- or third-degree atrioventricular (AV) block.
• Cardiogenic shock or overt heart failure.

Side Effects

Like all medications, Brimonidine/Timolol may cause side effects, including:

Common Side Effects

• Ocular effects:
• Eye irritation or redness
• Dry eyes
• Blurred vision
• Burning or stinging sensation

• Systemic effects:
• Fatigue and drowsiness
• Dizziness
• Headache
• Dry mouth

Serious Adverse Reactions

• Bradycardia (slow heart rate)
• Hypotension
• Bronchospasm in patients with respiratory disorders
• Depression and mood changes
• Severe allergic reactions (rare)

Patients experiencing significant side effects should seek medical attention.

Drug Interactions

Brimonidine/Timolol may interact with various medications:

• Beta-blockers (oral or topical) – May cause additive cardiovascular effects.
• Antihypertensive drugs – Can enhance hypotensive effects.
• CNS depressants (sedatives, alcohol, opioids) – Increased drowsiness.
• Monoamine oxidase inhibitors (MAOIs) – Risk of severe hypotension with brimonidine.

Patients should inform their healthcare provider about all medications they are taking.

Special Precautions

Pregnancy and Breastfeeding

• Pregnancy – Use only if the potential benefit outweighs the risk.
• Breastfeeding – Timolol is excreted in breast milk; caution is advised.

Use in Pediatric and Geriatric Populations

• Pediatrics: Not recommended for children under 2 years old due to the risk of central nervous system depression.
• Geriatrics: Increased risk of systemic beta-blockade effects.

Storage and Handling

• Store at room temperature (15-25°C).
• Keep the bottle tightly closed to prevent contamination.
• Avoid touching the dropper tip to any surface.
• Discard after the expiration date.

See Also

• Glaucoma
• Ocular hypertension
• Brimonidine
• Timolol
• Beta-blockers
• Alpha agonists

External Links

• NCBI – Research on Brimonidine/Timolol
• FDA Drug Database

This article is a stub related to pharmacology. You can help WikiMD by expanding it!